Envista Holdings Corporation
dental business
NVST NYSE
ISIN US29415F1049 SEC CIK 1757073 LEI 549300BX623VURJZ5269
Follow Envista
Weekly email: filings, results
Revenue, last quarter
$691.5M
+3.2% vs same quarter last year
Net income
$508.3M
+1777.6% vs same quarter last year
EPS, diluted
$3.11
+1827.8% vs same quarter last year
Operating cash flow
$77.9M
−1% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.7B | $47M |
| FY24 | $2.5B | −$1.1B |
| FY23 | $2.6B | −$100.2M |
| FY22 | $2.6B | $243.1M |
| FY21 | $2.5B | $340.5M |
| FY20 | $1.9B | $33.3M |
| FY19 | $2.3B | $217.6M |
| FY18 | $2.8B | $230.7M |
| FY17 | $2.8B | $301.1M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 54.7% | 7.9% | 1.7% |
| FY24 | 54.7% | −41.4% | −44.6% |
| FY23 | 56.1% | 1.2% | −3.9% |
| FY22 | 57.4% | 12.4% | 9.5% |
| FY21 | 56.9% | 12.2% | 13.6% |
| FY20 | 54.7% | 2.3% | 1.7% |
| FY19 | 59.1% | 10.3% | 9.5% |
| FY18 | 56.3% | 10.5% | 8.1% |
| FY17 | 57.7% | 13.8% | 10.7% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $230.4M |
| FY24 | $302.7M |
| FY23 | $217.5M |
| FY22 | $107M |
| FY21 | $306.9M |
| FY20 | $236.2M |
| FY19 | $319.7M |
| FY18 | $327.9M |
| FY17 | $310.2M |
- Envista
- Healthcare median
Show the numbers
| Year | Envista | Healthcare median |
|---|---|---|
| FY25 | 1.7% | −30.6% |
| FY24 | −44.6% | −47% |
| FY23 | −3.9% | −58% |
| FY22 | 9.5% | −80.4% |
| FY21 | 13.6% | −71.9% |
| FY20 | 1.7% | −62.2% |
| FY19 | 9.5% | −46.3% |
| FY18 | 8.1% | −49.6% |
| FY17 | 10.7% | −45.9% |